INTELLIGENCE IN ACTION

HIMSS18 Panel Gets Candid About Prescription Price Transparency

March 22, 2018

In advance of its highly anticipated conference—widely regarded as the world’s largest health information tradeshow—HIMSS posed this question on its homepage: “Are you ready for the next step in health?” Based on the enthusiasm of the more than 40,000 people who traveled to Las Vegas for this year’s show, the answer was a resounding “yes!”

That same excitement and passion for innovation was evident in the panel discussion we hosted in our booth: Bringing Prescription Price Transparency to the Point of Care. Pat Salber from The Doctor Weighs In moderated a lively discussion that included Casey Leonetti of CVS Health, Dr. Lynne Nowak of Express Scripts, Neil Simon of Aprima Medical Software and our very own Tom Skelton.

Our esteemed panelists explored a number of key challenges and opportunities related to prescription price transparency. According to Dr. Nowak, “[Physicians] care about the patient sitting in front of them and whether that patient can afford the medication or whether that patient is getting the best price within their benefits. So giving visibility … not only to the cost of the medication that is the initial choice, but [also to] those therapeutic alternatives is critical.”

In November 2017, Surescripts announced plans to revolutionize the prescription decision-making process with its Real-Time Prescription Benefit and expanded Prior Authorization solutions. Surescripts has joined forces with six electronic health records (EHR) companies, including Allscripts, Aprima, Cerner, Epic and GE Healthcare, and is leveraging information from pharmacy benefit managers (PBMs) CVS Health and Express Scripts to deliver patient-specific benefit and price information to providers in real time at the point of care.

Watch the panel discussion to learn how delivering patient-specific drug benefit and cost information to the point of care is revolutionizing a critical step in the e-prescribing process—all while improving medication adherence, patient care and costs. Then, take a peek at our Real-Time Prescription Benefit webpage. It’s indeed time to take the next step in health.

Related Articles

March 04, 2020

Prescription Price Transparency: Good for Patients, Good for Health Plans

Receiving a diagnosis at a routine doctor’s appointment can be incredibly scary, even for something as treatable as type 2 diabetes. But the right price transparency tools—or lack thereof—can make (or break) that experience for a patient.  Read more...
February 25, 2020

Price Transparency: It’s in the Best Interest of Patients and Providers

“In all my years in health IT this is one of the most exciting and most rapidly adopted clinical decision support tools I’ve ever been associated with,” said Andrew Mellin, MD and vice president of Medical Informatics at Surescripts, referring to Surescripts’ prescription price transparency tool Read more...
February 18, 2020

Patients Are Ready to Talk Dollars with Their Doctors

With more skin in the game than ever before, patients are becoming savvy, engaged and discerning consumers. They know that the name-brand drug with the $300 monthly price tag may not be the only option. They want a healthcare provider who has the information needed to compare and guide them to alternatives that achieve the same or similar outcome. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX